RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 56-66
  • Big pharma should support the NIH

    Big pharma should support the NIH
    Recently at a reception, one of my faculty colleagues at Johns Hopkins expressed concern about her academic future. The pay line for National Institutes of Health (NIH) grants in her field was 7 percent; that means that she has to spend two or three weeks...
  • FDA approves Amgen heart failure drug Corlanor

    FDA approves Amgen heart failure drug Corlanor
    Biotech company Amgen Inc. took a key step in its expansion into cardiovascular drugs Wednesday when the Food and Drug Administration approved its heart failure drug for sale in the United States. The drug called ivabradine is an oral medication that...
  • Antidepressants: a deadly treatment?

    Antidepressants: a deadly treatment?
    The crash of Germanwings Flight 9525, allegedly the intentional act of co-pilot Andreas Lubitz, and the deaths of all 150 people on board is indeed a tragedy. But some good may come out of it if it induces people to take another look at those substances...
  • FDA: Hospira's corrective actions at Italy plant weren't enough

     FDA: Hospira's corrective actions at Italy plant weren't enough
    The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing. The FDA in a March 31 letter said Hospira lacked written...
  • 'Right To Try' Law Won't Grant Access To Unapproved Drugs

    'Right To Try' Law Won't Grant Access To Unapproved Drugs
    Last month, the General Assembly's Public Health Committee unanimously approved and sent to the House floor a bill that purports to grant terminally ill patients access to medicines and therapies not yet approved by the federal Food and Drug...
  • Malloy Sales Tax Cut To Be Part Of Broader Spending Plan

    Malloy Sales Tax Cut To Be Part Of Broader Spending Plan
    MIDDLETOWN – Consumers would no longer pay a sales tax on over-the-counter-drugs, but they would continue to pay taxes on clothing and footwear costing less than $50 under a proposal outlined Monday by Gov. Dannel P. Malloy. Both taxes were...
  • With purchase of EnvisionRx, Rite Aid gets in on the drug intermediary racket

     With purchase of EnvisionRx, Rite Aid gets in on the drug intermediary racket
    John Standley, chief executive of the Rite Aid pharmacy chain, was effusive this week in describing how consumers will benefit from his company spending $2 billion to buy EnvisionRx, a firm most people likely never heard of. The deal, he said, will...
  • Help curb the devastation of prescription drug abuse

    Help curb the devastation of prescription drug abuse
    We get the calls every day. Parents, siblings, grandparents and friends are reaching out to our organization worried that their loved one is abusing prescription medicine. Prescription drug abuse is an epidemic and is skyrocketing among our nation's...
  • FDA: Lehigh County company mislabeled cough syrup

    FDA: Lehigh County company mislabeled cough syrup
    Federal authorities have notified a Lehigh County company it must change the way it sells products portrayed as therapeutic cough syrup. A U.S. Food and Drug Administration "warning letter" sent to Fragrance Manufacturing Inc. of Hanover Township says...
  • Hospira earnings hit some targets, miss on others

    Hospira earnings hit some targets, miss on others
    Hospira, the Lake Forest-based maker of injectable and biotechnology drugs, reported fourth-quarter and full-year 2014 earnings Thursday. The company plans to sell to pharmaceutical giant Pfizer in the second half of 2015 for $15.23 billion. Here's...
  • Hospira to help biosimilar company Pfenex develop vision treatment

    Hospira to help biosimilar company Pfenex develop vision treatment
    Hospira shares got a big boost last week when Pfizer agreed to buy the company for $15.23 billion. This week, Hospira is paying it forward to a small pharmaceutical company in California, agreeing to help it develop a drug. Pfenex, which issued its...